These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26966144)

  • 1. Focus on harm reduction in fight against HIV, says report.
    Cousins S
    BMJ; 2016 Mar; 352():i1479. PubMed ID: 26966144
    [No Abstract]   [Full Text] [Related]  

  • 2. Harm reduction interventions should encompass people who inject image and performance enhancing drugs.
    McVeigh J; Kimergård A; Bates G; Hope VD; Ncube F
    BMJ; 2016 Apr; 353():i1889. PubMed ID: 27048560
    [No Abstract]   [Full Text] [Related]  

  • 3. Late for the epidemic: HIV/AIDS in Eastern Europe.
    Cohen J
    Science; 2010 Jul; 329(5988):160, 162-4. PubMed ID: 20616262
    [No Abstract]   [Full Text] [Related]  

  • 4. No opiate substitutes for the masses of IDUs.
    Cohen J
    Science; 2010 Jul; 329(5988):165-7. PubMed ID: 20616264
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of harm reduction programmes in Russia.
    Lancet; 2009 Oct; 374(9697):1213. PubMed ID: 19819371
    [No Abstract]   [Full Text] [Related]  

  • 6. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring harm reduction in European prisons via the Dublin Declaration.
    Lines R; Stöver H; Donochoe MC; Lazarus JV
    Int J Prison Health; 2009; 5(4):251-5. PubMed ID: 25757526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young people and drugs: next generation of harm reduction.
    Merkinaite S; Grund JP; Frimpong A
    Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physical health of people who inject drugs: complexities, challenges, and continuity.
    Cornford C; Close H
    Br J Gen Pract; 2016 Jun; 66(647):286-7. PubMed ID: 27231287
    [No Abstract]   [Full Text] [Related]  

  • 11. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary health care for people who inject drugs in low and middle income countries.
    Myers BJ
    Int J Drug Policy; 2012 Mar; 23(2):105-6. PubMed ID: 22030256
    [No Abstract]   [Full Text] [Related]  

  • 13. Russia, the G8, and HIV.
    Malinowska-Sempruch K
    Lancet; 2006 Aug; 368(9534):446. PubMed ID: 16890821
    [No Abstract]   [Full Text] [Related]  

  • 14. State of the art science addressing injecting drug use, HIV and harm reduction.
    Beg M; Strathdee SA; Kazatchkine M
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S1-4. PubMed ID: 25727257
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences.
    Byrne J; Albert ER
    Int J Drug Policy; 2010 Mar; 21(2):110-1. PubMed ID: 19942422
    [No Abstract]   [Full Text] [Related]  

  • 16. Crime and unjust punishment in Russia.
    Parfitt T
    Lancet; 2010 Nov; 376(9755):1815-6. PubMed ID: 21128336
    [No Abstract]   [Full Text] [Related]  

  • 17. Russia's blossoming civil society holds the key to HIV.
    Brown H
    Lancet; 2006 Aug; 368(9534):437-40. PubMed ID: 16894651
    [No Abstract]   [Full Text] [Related]  

  • 18. Could a United Nations organisation lead to a worsening of drug-related harms?
    Wood E; Kerr T
    Drug Alcohol Rev; 2010 Jan; 29(1):99-100. PubMed ID: 20078689
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-prevention strategies.
    Gostin L
    Lancet; 1997 May; 349(9062):1394-5. PubMed ID: 9149721
    [No Abstract]   [Full Text] [Related]  

  • 20. The Latin American harm reduction network (RELARD): successes and challenges.
    Bueno R
    Int J Drug Policy; 2007 Mar; 18(2):145-7. PubMed ID: 17689358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.